Rothschild & CO Asset Management Us Inc. Charles River Laboratories International, Inc. Transaction History
Rothschild & CO Asset Management Us Inc.
- $6.56 Billion
- Q4 2022
A detailed history of Rothschild & CO Asset Management Us Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Rothschild & CO Asset Management Us Inc. holds 23,402 shares of CRL stock, worth $4.27 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
23,402
Previous 23,546
0.61%
Holding current value
$4.27 Million
Previous $4.63 Million
9.99%
% of portfolio
0.08%
Previous 0.08%
Shares
22 transactions
Others Institutions Holding CRL
# of Institutions
694Shares Held
52.2MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.11 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$929 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$683 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$389 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$354 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.29B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...